Altimmune, Inc. (ALT)
NASDAQ: ALT · IEX Real-Time Price · USD
6.74
-0.46 (-6.39%)
At close: Jul 2, 2024, 4:00 PM
6.83
+0.09 (1.34%)
After-hours: Jul 2, 2024, 7:59 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Altimmune stock have an average target of 18.8, with a low estimate of 12 and a high estimate of 25. The average target predicts an increase of 178.93% from the current stock price of 6.74.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Altimmune stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +196.74% | Jun 25, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $25 | Buy | Maintains | $25 | +270.92% | Jun 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +78.04% | May 14, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $25 → $24 | Buy | Maintains | $25 → $24 | +256.08% | May 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 29, 2024 |
Financial Forecast
Revenue This Year
3.36K
from 426.00K
Decreased by -99.21%
Revenue Next Year
n/a
from 3.36K
EPS This Year
-1.55
from -1.66
EPS Next Year
-1.57
from -1.55
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 21,000 | n/a | n/a | 135.1M | 1.7B |
| Avg | 3,363 | n/a | n/a | 32.9M | 387.2M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -95.1% | - | - | - | 5,119.4% |
| Avg | -99.2% | - | - | - | 1,075.7% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.24 | -1.22 | -1.25 | -0.47 | 11.82 |
| Avg | -1.55 | -1.57 | -1.71 | -1.42 | 3.00 |
| Low | -2.39 | -2.00 | -2.20 | -2.28 | -2.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.